{"id":"NCT04174170","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","briefTitle":"Brexpiprazole as Combination Therapy With Sertraline in the Treatment of Adults With Post-traumatic Stress Disorder","officialTitle":"A Phase 3, Multicenter, Randomized, Double-blind Trial of Fixed-Dose Brexpiprazole as Combination Therapy With Sertraline in the Treatment of Adults With Post-traumatic Stress Disorder","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-10-30","primaryCompletion":"2023-07-25","completion":"2023-08-15","firstPosted":"2019-11-22","resultsPosted":"2025-05-30","lastUpdate":"2025-05-30"},"enrollment":591,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Post Traumatic Stress Disorder"],"interventions":[{"type":"DRUG","name":"Brexpiprazole","otherNames":["Rexulti"]},{"type":"DRUG","name":"Sertraline","otherNames":["Zoloft"]},{"type":"OTHER","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Brexpiprazole","otherNames":["Rexulti"]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Brexpiprazole (2 mg) + Sertraline","type":"EXPERIMENTAL"},{"label":"Brexpiprazole (3 mg) + Sertraline","type":"EXPERIMENTAL"},{"label":"Sertraline + Placebo","type":"EXPERIMENTAL"}],"summary":"This will be a 12-week, multicenter, randomized, double-blind trial evaluating the efficacy, safety, and tolerability of fixed-dose brexpiprazole + sertraline combination treatment in adult subjects with post-traumatic stress disorder.","primaryOutcome":{"measure":"Change From Baseline in Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) Total Score","timeFrame":"Baseline (Week 1), Week 10","effectByArm":[{"arm":"Brexpiprazole (2 mg) + Sertraline","deltaMin":-16.53,"sd":1.19},{"arm":"Brexpiprazole (3 mg) + Sertraline","deltaMin":-18.28,"sd":1.23},{"arm":"Sertraline + Placebo","deltaMin":-17.57,"sd":1.19}],"pValues":[{"comp":"OG000 vs OG002","p":"0.5165"},{"comp":"OG001 vs OG002","p":"0.6593"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":4},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":185},"commonTop":["Nausea","Headache","Diarrhoea","Insomnia"]}}